Beyond Polymyositis: Refractory Lumbar Spasms Revealing Underlying Isaac Syndrome
Keywords:
Isaac syndrome, Polymyositis, neuromyotonia, plasma exchange, Autoimmune DiseasesAbstract
Background: Polymyositis is an idiopathic inflammatory myopathy characterized by proximal muscle weakness, elevated creatine kinase (CK), and immune-mediated pathogenesis. Atypical features such as refractory shock-like paraspinal spasms should prompt consideration of a coexisting diagnosis. Isaac syndrome (neuromyotonia) is a rare autoimmune peripheral nerve hyperexcitability disorder classically associated with voltage-gated potassium channel (VGKC) antibodies, though antibodies against glutamic acid decarboxylase 65 (anti-GAD65) have also been implicated in peripheral nerve hyperexcitability syndromes. The clinical overlap between inflammatory myopathy and Isaac syndrome poses a significant diagnostic challenge, as their management and prognosis differ substantially. Early serological and clinical recognition is critical to guide appropriate immunotherapy and prevent systemic complications.
The Case: A 72-year-old male with inflammatory myopathy, scoliosis, and hypertension presented with repetitive shock-like lumbar spasms every 5 seconds. Neurological examination was otherwise unremarkable. Laboratory workup revealed CK 181 U/L, lactate 3.7 mmol/L, and mildly elevated troponin consistent with cardiac demand injury from sustained muscle hyperactivity. Importantly, anti-GAD65 antibodies returned positive at 6.9 nmol/L, providing serological support of an autoimmune neurological process. The disproportionately low CK relative to spasm severity, combined with anti-GAD65 seropositivity, pointed toward a neuromuscular rather than primary myopathic etiology. Initial treatment with intravenous methylprednisolone and intramuscular orphenadrine failed. Given clinical suspicion for autoimmune neuromuscular hyperexcitability, Isaac syndrome was diagnosed and plasma exchange (PLEX) was initiated. The patient demonstrated marked improvement in spasms, resolution of lactic acidosis, and normalization of cardiac biomarkers. He was discharged on prednisone taper and methotrexate with outpatient neurology and rheumatology follow-up.
Conclusion: This case highlights that refractory shock-like spasms in the context of polymyositis should raise suspicion for coexisting autoimmune neuromyotonia. A low CK combined with poor steroid response are important clues toward an underlying peripheral nerve hyperexcitability syndrome. Anti-GAD65 seropositivity at high titer provided serological support for the autoimmune etiology and underscores the importance of a broad antibody workup in atypical inflammatory myopathy. Sustained involuntary muscle activity carries risk of serious metabolic complications including lactic acidosis and demand myocardial injury. Standard corticosteroids may be insufficient in GAD65-associated neuromyotonia, and early escalation to PLEX or other immunotherapies should be considered. A multidisciplinary approach involving neurology and rheumatology is essential to optimize outcomes.
Downloads
Published
How to Cite
License
Copyright (c) 2026 Anuraga Meyyappan, Monte Mohana, Anaira Guzman, Yanet Rios

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- The Author retains copyright in the Work, where the term “Work” shall include all digital objects that may result in subsequent electronic publication or distribution.
- Upon acceptance of the Work, the author shall grant to the Publisher the right of first publication of the Work.
- The Author shall grant to the Publisher and its agents the nonexclusive perpetual right and license to publish, archive, and make accessible the Work in whole or in part in all forms of media now or hereafter known under a Creative Commons Attribution 4.0 International License or its equivalent, which, for the avoidance of doubt, allows others to copy, distribute, and transmit the Work under the following conditions:
- Attribution—other users must attribute the Work in the manner specified by the author as indicated on the journal Web site; with the understanding that the above condition can be waived with permission from the Author and that where the Work or any of its elements is in the public domain under applicable law, that status is in no way affected by the license.
- The Author is able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the Work (e.g., post it to an institutional repository or publish it in a book), as long as there is provided in the document an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post online a prepublication manuscript (but not the Publisher’s final formatted PDF version of the Work) in institutional repositories or on their Websites prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. Any such posting made before acceptance and publication of the Work shall be updated upon publication to include a reference to the Publisher-assigned DOI (Digital Object Identifier) and a link to the online abstract for the final published Work in the Journal.
- Upon Publisher’s request, the Author agrees to furnish promptly to Publisher, at the Author’s own expense, written evidence of the permissions, licenses, and consents for use of third-party material included within the Work, except as determined by Publisher to be covered by the principles of Fair Use.
- The Author represents and warrants that:
- the Work is the Author’s original work;
- the Author has not transferred, and will not transfer, exclusive rights in the Work to any third party;
- the Work is not pending review or under consideration by another publisher;
- the Work has not previously been published;
- the Work contains no misrepresentation or infringement of the Work or property of other authors or third parties; and
- the Work contains no libel, invasion of privacy, or other unlawful matter.
- The Author agrees to indemnify and hold Publisher harmless from the Author’s breach of the representations and warranties contained in Paragraph 6 above, as well as any claim or proceeding relating to Publisher’s use and publication of any content contained in the Work, including third-party content.
Enforcement of copyright
The IJMS takes the protection of copyright very seriously.
If the IJMS discovers that you have used its copyright materials in contravention of the license above, the IJMS may bring legal proceedings against you seeking reparation and an injunction to stop you using those materials. You could also be ordered to pay legal costs.
If you become aware of any use of the IJMS' copyright materials that contravenes or may contravene the license above, please report this by email to contact@ijms.org
Infringing material
If you become aware of any material on the website that you believe infringes your or any other person's copyright, please report this by email to contact@ijms.org



